The study emphasizes the negative regulation of the Ras/MEK/ERK pathway as a key mechanism contributing to the enhanced efficacy of SFN in combination with PDT against anaplastic thyroid cancer [125]. Here, MAP2K7 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.